400 related articles for article (PubMed ID: 30876667)
1. Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer.
Zhao H; Huang T; Li H
Surgery; 2019 Jul; 166(1):55-60. PubMed ID: 30876667
[TBL] [Abstract][Full Text] [Related]
2. Predicting skip metastasis in lateral lymph nodes of papillary thyroid carcinoma based on clinical and ultrasound features.
Zhao M; Shi X; Zou Z; Wen R; Lu Y; Li J; Cao J; Zhang B
Front Endocrinol (Lausanne); 2023; 14():1151505. PubMed ID: 37229457
[TBL] [Abstract][Full Text] [Related]
3. Lateral lymph node metastasis in papillary thyroid cancer: Is there a difference between PTC and PTMC?
Ma W; Guo Y; Hua T; Li L; Lv T; Wang J
Medicine (Baltimore); 2024 Apr; 103(17):e37734. PubMed ID: 38669400
[TBL] [Abstract][Full Text] [Related]
4. The importance of sentinel lymph node diagnostic biopsy from the lateral neck compartment in the surgical treatment of papillary thyroid cance.
Arciniegas LM; Reken V; Nemergut S; Sabol M; Durdik S; Kralik R
Bratisl Lek Listy; 2023; 124(11):827-832. PubMed ID: 37874805
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic central lymph node dissection in cN0 papillary thyroid cancer: a comparative study of via breast and transoral approach versus via breast approach alone.
Qiu R; Fu J
Front Endocrinol (Lausanne); 2024; 15():1356739. PubMed ID: 38774230
[TBL] [Abstract][Full Text] [Related]
6. Central node dissection from the perspective of lateral neck node metastasis in papillary thyroid carcinoma.
Taniuchi M; Kawata R; Terada T; Higashino M; Aihara T; Jinnin T
Auris Nasus Larynx; 2024 Apr; 51(2):266-270. PubMed ID: 37945422
[TBL] [Abstract][Full Text] [Related]
7. Clinical impact of coexistent chronic lymphocytic thyroiditis on central lymph node metastasis in low- to intermediate-risk papillary thyroid carcinoma: The MASTER study.
Heo DB; Won HR; Tae K; Kang YE; Jeon E; Ji YB; Chang JW; Choi JY; Yu HW; Ku EJ; Lee EK; Kim M; Choe JH; Koo BS;
Surgery; 2024 Apr; 175(4):1049-1054. PubMed ID: 38281855
[TBL] [Abstract][Full Text] [Related]
8. Level II lateral neck dissection for papillary thyroid carcinoma: A retrospective cohort study.
Lv T; Ma WL; Tan Z; Jiang LH; Liang JY; Wu JJ; Hou CJ; Ge MH; Wang JF
Asian J Surg; 2023 Oct; 46(10):4290-4295. PubMed ID: 37085417
[TBL] [Abstract][Full Text] [Related]
9. Central lymph nodes in frozen sections can effectively guide extended lymph node resection for papillary thyroid carcinoma.
Peng L; Zheng X; Xue Y; Huang C; Su X; Yu S
Ann Med; 2023; 55(2):2286337. PubMed ID: 38061392
[TBL] [Abstract][Full Text] [Related]
10. Impact of age on central lymph nodes involvement in papillary thyroid cancer.
Awny S; Abdallah A; Metwally IH; Abdelwahab K; Zuhdy M; Hamdy O; Fareed AM; Atallah K
BMC Cancer; 2024 Apr; 24(1):423. PubMed ID: 38580902
[TBL] [Abstract][Full Text] [Related]
11. Risk factors associated with preferential lateral lymph node metastasis in papillary thyroid carcinoma.
Shao L; Wang Z; Dong W; Sun W; Zhang H
Cancer Med; 2023 Nov; 12(22):20670-20676. PubMed ID: 37905599
[TBL] [Abstract][Full Text] [Related]
12. The lymph node yield in the initial lateral neck dissection predicts recurrence in the lateral neck of papillary thyroid carcinoma: a revision surgery cohort study.
Yu ST; Ge J; Wei Z; Sun B; Xiao Z; Li T; Zhang Z; Chen W; Lei ST
Int J Surg; 2023 May; 109(5):1264-1270. PubMed ID: 37080561
[TBL] [Abstract][Full Text] [Related]
13. Predictive Value of Jugulo-omohyoid Lymph Nodes in Lateral Lymph Node Metastasis of Papillary Thyroid Cancer.
Cai H; Zhuge L; Huang Z; Wang S; Shi P; Yan D; Wei M; Niu L; Li Z
BMC Endocr Disord; 2024 May; 24(1):74. PubMed ID: 38773428
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of clinicopathologic and sonographic features in thyroid cancer with skip lymph node metastasis: establish and assessment of a prediction nomogram.
Jiwang L; Jinghui B; Fengqin F; Tao Y; Yuejiao Z
Braz J Otorhinolaryngol; 2023; 89(5):101301. PubMed ID: 37579569
[TBL] [Abstract][Full Text] [Related]
15. In Reference to Prophylactic Central Neck Dissection for Clinically Node-Negative Papillary Thyroid Carcinoma.
Maso V; Morvan JB; Dagain A; Beucler N
Laryngoscope; 2023 Nov; 133(11):E64-E65. PubMed ID: 37497851
[No Abstract] [Full Text] [Related]
16. Should multifocality be an indication for prophylactic central neck dissection in papillary thyroid cancer?
Ozdemir K; Harmantepe AT; Gonullu E; Kocer B; Bayhan Z
Updates Surg; 2023 Apr; 75(3):701-706. PubMed ID: 36871277
[TBL] [Abstract][Full Text] [Related]
17. The proposed modification of TNM staging and therapeutic strategy for skip metastasis in papillary thyroid carcinoma: A multicenter retrospective cohort study.
Yang Z; Heng Y; Zhao Q; Hao D; Tao L; Deng X; Cai W; Qiu W
Cancer Med; 2023 Jun; 12(12):13270-13278. PubMed ID: 37140212
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of risk factors for recurrence of differentiated thyroid carcinoma after surgical resection combined with iodine-131 and TSH suppression therapy].
Ye T; Lai S; Cao B; Xu B; Wang R
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 May; 37(5):370-374. PubMed ID: 37138400
[No Abstract] [Full Text] [Related]
19. Diagnostic Model Incorporating Clinicopathological Characteristics of Delphian Lymph Node Metastasis Risk Profiles in Papillary Thyroid Cancer.
Li X; Duan Y; Liu D; Liu H; Zhou M; Yue K; Shuai Y; Wang Y; Ji C; Jing C; Wu Y; Wang X
Front Endocrinol (Lausanne); 2021; 12():591015. PubMed ID: 33841323
[TBL] [Abstract][Full Text] [Related]
20. The effect of extent of surgery and number of lymph node metastases on overall survival in patients with medullary thyroid cancer.
Esfandiari NH; Hughes DT; Yin H; Banerjee M; Haymart MR
J Clin Endocrinol Metab; 2014 Feb; 99(2):448-54. PubMed ID: 24276457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
